Medical Breakthrough with New Ovarian Cancer Drug
Researchers at the National Research Council’s head office in Ottawa, Ontario, Canada, have made a medical breakthrough in decreasing the rate at which ovarian cancer grows. Not only that, but new clinical trials conducted by both PharmaGap through the Ottawa Hospital Research Institute and the United States National Cancer Institute show that this treatment also works on many other types of cancer as well.
Researchers discovered a way of blocking the growth and spread of cancer cells. In all but one of their 14 strains of cancer on record and many of the 60 on which the U.S. NCI is now testing the drug, this new medication has been proven to decrease the rate of growth of the cancer.
The drug has entered the laboratory trial stage of testing and will be fully tested there before moving on to human clinical trials. Toxicology tests will also be done to measure any side effects that may be harmful to humans.
From the test tube to actual human clinical trials can take up to five years because there are so many avenues researchers have to look at before getting FDA approval for the drug and finally getting the drug ready for use.
Symptoms of Ovarian Cancer
Add A New CommentWe value and respect the experiences of all of our HerWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add A New CommentComments
There are no comments yet. Be the first to get the conversation started.